Nur Zeinomar, PhD, MPH is a cancer epidemiologist at Rutgers Cancer Institute in the Section of Cancer Epidemiology and Health Outcomes. The overarching aim of her research is to translate epidemiologic findings into clinical care through more accurate risk assessment and to optimize risk-reducing strategies for outcomes after a cancer diagnosis. Specifically, she is interested in understanding the role of genetics, the environment, lifestyle factors, and their interplay on breast cancer etiology and prognosis. Dr. Zeinomar is currently funded by the National Cancer Institute (K22CA251493-01A1) to examine the role of germline genetic variation (in the form of a polygenic risk score) in breast cancer prognosis. Her publications can be found here: MyNCBI and Google Scholar.
Prior to joining Rutgers, Dr. Zeinomar served as a TL1 post-doctoral fellow focused on precision medicine at the Columbia Irving Institute for Clinical and Translational Research (CTSA), Columbia University Mailman School of Public Health; New York, NY. She was also an NCI-funded T32 Post-Doctoral Research Scientist in Molecular and Cancer Epidemiology at Columbia University Mailman School of Public Health.
Contact: nz171@cinj.rutgers.edu
Research Interests:
- Epidemiology of breast cancer
- Breast cancer survivorship
- Cancer health disparities
- Lifestyle factors, environmental factors, genomic factors
- Microbiome
Laboratory Support
Current Support:
- 1. National Cancer Institute (NCI) Career Development Award K22 (K22CA251493-01A1)
Title: Leveraging high-risk populations for precision prevention: A novel approach for improving risk prediction for outcomes after a breast cancer diagnosis.
Role: Principal investigator - CINJ Cancer Prevention and Control (CPC) Pilot Award (P30CA072720-5931)
Title: Characterizing the gut microbiome in a cohort of Black and Hispanic breast cancer survivors: a pilot study.
Role: Principal investigator - 3. New Jersey Health Foundation (PC 153-23)
Title: Characterizing the Gut Microbiome in a Cohort of South Asian Breast Cancer Survivors: A Pilot Study.
Role: Principal investigator